Viewing Study NCT06613100


Ignite Creation Date: 2025-12-26 @ 12:15 PM
Ignite Modification Date: 2025-12-31 @ 9:36 PM
Study NCT ID: NCT06613100
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2024-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module